Investors bought shares of St. Jude Medical Inc. (NYSE:STJ) on weakness during trading on Tuesday. $44.47 million flowed into the stock on the tick-up and $28.80 million flowed out of the stock on the tick-down, for a money net flow of $15.67 million into the stock. Of all equities tracked, St. Jude Medical had the 22nd highest net in-flow for the day. St. Jude Medical traded down ($0.35) for the day and closed at $80.21

Several research firms have recently commented on STJ. Wedbush downgraded shares of St. Jude Medical from an “outperform” rating to a “neutral” rating and boosted their target price for the stock from $70.00 to $84.00 in a report on Friday. Leerink Swann cut shares of St. Jude Medical from an “outperform” rating to a “market perform” rating in a research report on Monday, July 11th. JPMorgan Chase & Co. restated a “hold” rating on shares of St. Jude Medical in a research report on Sunday. Needham & Company LLC cut shares of St. Jude Medical from a “buy” rating to a “hold” rating in a research report on Friday, April 29th. Finally, William Blair cut shares of St. Jude Medical from an “outperform” rating to a “market perform” rating in a research report on Friday, April 29th. Twenty-one equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $74.46.

The firm has a 50 day moving average price of $78.33 and a 200-day moving average price of $64.58. The firm has a market capitalization of $22.80 billion and a P/E ratio of 32.23.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 29th. Shareholders of record on Thursday, June 30th will be issued a $0.31 dividend. The ex-dividend date is Tuesday, June 28th. This represents a $1.24 dividend on an annualized basis and a yield of 1.55%.

A number of hedge funds and institutional investors have recently made changes to their positions in the stock. Advantus Capital Management Inc raised its position in shares of St. Jude Medical by 3.3% in the fourth quarter. Advantus Capital Management Inc now owns 27,189 shares of the medical technology company’s stock worth $1,679,000 after buying an additional 877 shares during the last quarter. Tekla Capital Management LLC raised its position in shares of St. Jude Medical by 58.4% in the fourth quarter. Tekla Capital Management LLC now owns 255,810 shares of the medical technology company’s stock worth $15,801,000 after buying an additional 94,300 shares during the last quarter. Vanguard Group Inc. raised its position in shares of St. Jude Medical by 2.6% in the fourth quarter. Vanguard Group Inc. now owns 16,138,642 shares of the medical technology company’s stock worth $996,883,000 after buying an additional 411,462 shares during the last quarter. State of Wisconsin Investment Board raised its position in shares of St. Jude Medical by 6.5% in the fourth quarter. State of Wisconsin Investment Board now owns 398,262 shares of the medical technology company’s stock worth $24,601,000 after buying an additional 24,330 shares during the last quarter. Finally, Dorsey & Whitney Trust CO LLC raised its position in shares of St. Jude Medical by 6.9% in the fourth quarter. Dorsey & Whitney Trust CO LLC now owns 54,103 shares of the medical technology company’s stock worth $3,343,000 after buying an additional 3,484 shares during the last quarter.

St. Jude Medical, Inc is focused on the development, manufacture and distribution of cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.